Diet as a strategy for type 1 diabetes prevention

Cellular and Molecular Immunology

Volumn 15, Issue 1, 2018, Pages 1-4

  Prodam, Flavia ^a   Chiocchetti, Annalisa ^a   Dianzani, Umberto ^a  

^a UNIVERSITY OF EASTERN PIEDMONT   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID; AMINO ACID; BILE ACID; BUTYRIC ACID; G PROTEIN COUPLED RECEPTOR; HISTONE DEACETYLASE; HLA ANTIGEN; HORMONE; OCCLUDIN; SHORT CHAIN FATTY ACID; VITAMIN;

ALLELE; ANTIBIOTIC SENSITIVITY; ANTIGEN PRESENTING CELL; AUTOIMMUNE DISEASE; AUTOIMMUNITY; BACTEROIDES; CELIAC DISEASE; CELL EXPANSION; CELL PROLIFERATION; CELLULAR IMMUNITY; DIET SUPPLEMENTATION; DIET THERAPY; DISEASE ASSOCIATION; DISEASE BURDEN; DISEASE COURSE; DRUG SAFETY; DYSBIOSIS; ECOSYSTEM HEALTH; ENCEPHALOMYELITIS; ENDOCRINE CELL; ENVIRONMENTAL FACTOR; ENZYME ACTIVITY; ENZYME INHIBITION; FECES MICROFLORA; GASTROINTESTINAL DISEASE; GENETIC BACKGROUND; GENETIC PREDISPOSITION; GENETIC TRANSCRIPTION; GLUCOSE METABOLISM; HELPER CELL; HIGH RISK POPULATION; HOMEOSTASIS; HUMAN; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IMMUNOREACTIVITY; INCIDENCE; INFLAMMATION; INSULIN DEPENDENT DIABETES MELLITUS; INSULITIS; INTESTINE FLORA; LIPID METABOLISM; LYMPH NODE; LYMPHOCYTIC INFILTRATION; MICROBIAL ACTIVITY; MICROBIAL CONSORTIUM; MICROFLORA; MUCOSAL IMMUNITY; MULTIPLE SCLEROSIS; MYELIN SHEATH; NERVE CELL; NONHUMAN; NOTE; ONSET AGE; PANCREAS ISLET BETA CELL; PATHOGENESIS; PHYSIOLOGY; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; RISK FACTOR; THERAPY EFFECT; DIET; EXERCISE; T LYMPHOCYTE;

DIABETES MELLITUS, TYPE 1; DIET; EXERCISE; GASTROINTESTINAL MICROBIOME; HUMANS; T-LYMPHOCYTES;

EID: 85041185089     PISSN: 16727681     EISSN: None     Source Type: Journal    
DOI: 10.1038/cmi.2017.54     Document Type: Note

References (13)

1. Marinõ E, Richards JL, McLeod KH, Stanley D, Yap YA, Knight J, et al. Gut microbial metabolites limit the frequency of autoimmune T cells and protect against type 1 diabetes. Nat Immunol 2017; 18: 552-562.
2. Patterson CC, Dahlquist GG, Gyürüs E, Green A, Soltész GEURODIAB Study Group. Incidence trends for childhood type 1 diabetes in Europe during 1989-2003 and predicted new cases 2005-20: A multicentre prospective registration study. Lancet 2009; 373: 2027-2033.
3. Insel R, Dunne JL. JDRF's vision and strategy for prevention of type 1 diabetes. Pediatr Diabetes 2016; 17(Suppl 22): 87-92.
4. Rewers M, Ludvigsson J. Environmental risk factors for type 1 diabetes. Lancet 2016; 387: 2340-2348.
5. Clarke G, Stilling RM, Kennedy PJ, Stanton C, Cryan JF, Dinan TG. Minireview: Gut microbiota: The neglected endocrine organ. Mol Endocrinol 2014; 28: 1221-1238.
6. Husted AS, Trauelsen M, Rudenko O, Hjorth SA, Schwartz TW. GPCR-mediated signaling of metabolites. Cell Metab 2017; 25: 777-796.
7. Dianzani U, Chiocchetti A, Ramenghi U. Role of inherited defects decreasing Fas function in autoimmunity. Life Sci 2003; 72: 2803-2824.
8. DeFranco S, Bonissoni S, Cerutti F, Bona G, Bottarel F, Cadario F, et al. Defective function of Fas in patients with type 1 diabetes associated with other autoimmune diseases. Diabetes 2001; 50: 483-488.
9. Comi C, Fleetwood T, Dianzani U. The role of T cell apoptosis in nervous system autoimmunity. Autoimmun Rev 2012; 12: 150-156.
10. Lee YK, Menezes JS, Umesaki Y, Mazmanian SK. Proinflammatory T-cell responses to gut microbiota promote experimental autoimmune encephalomyelitis. Proc Natl Acad Sci USA 2011; 108(Suppl 1): 4615-4622.
11. Dunne JL, Triplett EW, Gevers D, Xavier R, Insel R, Danska J, et al. The intestinal microbiome in type 1 diabetes. Clin Exp Immunol 2014; 177: 30-37.
12. Nishio J, Honda K. Immunoregulation by the gut microbiota. Cell Mol Life Sci 2012; 69: 3635-3650.
13. Zheng Y, Wang Z, Zhou Z. miRNAs: Novel regulators of autoimmunity-mediated pancreatic-cell destruction in type 1 diabetes. Cell Mol Immunol 2017; 14: 488-496.